NMN vs. NR: Which NAD+ Booster Actually Has Better Evidence?

4 Human Trials Compared 3 Products Compared

Last reviewed September 2026

NMN and NR are the two most common ingredients in the NAD+/longevity supplement category, and they’re often marketed as if one is clearly superior. Having read the actual human trials behind three products in this space, our honest answer is: there’s no direct head-to-head trial declaring a winner, both have real evidence, and the more useful question is which specific study’s population and results best match your situation.

The Basic Difference

Both NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are precursor molecules the body converts into NAD+ — a molecule every cell needs for energy production and DNA repair, and one that declines with age. They sit at slightly different points in the same biological pathway. There’s ongoing scientific debate about which conversion route is more efficient in humans, but at the level of actual published human trials, both have real, independent support — which puts this category well ahead of most others we cover.

The Evidence for NMN

Yoshino et al., 2021, Science (PMID 33888596). A 10-week trial in 25 postmenopausal women with prediabetes, using 250mg/day NMN. Significantly improved muscle insulin sensitivity and signaling versus placebo — a real, prestigious-journal result, though tested in a specific population that doesn’t include men.
Huang et al., 2022, Frontiers in Aging (PMID 35821806). A 60-day trial in 66 adults aged 40–65 (a broader, mixed population), using 300mg/day NMN. NAD+/NADH rose 38% versus 14.3% in placebo, alongside improved walking endurance and insulin resistance markers.

We reviewed GenuinePurity’s Liposomal NMN (which matches the Yoshino dose) and ProHealth’s NMN Pro 300 (which matches the Huang dose). Both cite real, dose-matched research — a genuine strength for both products.

The Evidence for NR

Martens et al., 2018, Nature Communications (PMID 29599478). Independently funded (not by the manufacturer), conducted at the University of Colorado Boulder. 1,000mg/day NR for 6 weeks raised NAD+ by roughly 60% in adults aged 55–79, with secondary findings suggesting improved arterial stiffness.
Conze et al., 2019, Scientific Reports (PMID 31278280). Company-funded, dose-ranging trial. At 300mg/day — a directly comparable dose to the NMN studies above — NAD+ rose about 51%. At 1,000mg/day, it rose 142%.

We reviewed Tru Niagen, which cites both studies. The independently-funded Martens trial is a genuine differentiator — it’s the only study among all three products that wasn’t funded by the ingredient’s manufacturer.

Is One Actually Better?

Based purely on the numbers: at a comparable 300mg dose, the NR study (Conze, company-funded) showed a 51% NAD+ increase, versus 38% in the NMN study (Huang, also company-funded). That’s not nothing, but it’s also not a controlled, head-to-head comparison — different labs, different populations, different countries, run years apart. We wouldn’t treat a 13-percentage-point gap between two separate studies as proof one ingredient beats the other. What we can say with more confidence: NR currently has the only independently funded human trial of the three studies here, which is a real point in its favor on the “can we trust this beyond the manufacturer’s word” question specifically — separate from the raw percentage numbers.

NMN’s Recent Legal History

From 2022 to late 2025, NMN existed in a genuine U.S. regulatory gray area — the FDA had excluded it from the legal definition of a dietary supplement because it was under investigation as a drug by another company. That was resolved in September and December 2025, when the FDA confirmed NMN is lawfully marketed as a supplement. NR, sold under the Niagen brand, didn’t go through this same gray period. If you encountered conflicting information about NMN’s legality in the past, this is why — and the situation is now resolved either way.

How Real Products Compare

ProductIngredientDoseUnderlying Study
GenuinePurity NMNNMN250mgYoshino 2021, Science (women only)
ProHealth NMN Pro 300NMN300mgHuang 2022, Frontiers in Aging (mixed sex)
Tru NiagenNR (Niagen®)150/300/1,000mgMartens 2018 (independent) & Conze 2019

FAQ

Which is better, NMN or NR?

There’s no direct head-to-head human trial declaring a winner. Both have real, peer-reviewed human research behind them. NR currently has the only independently-funded trial among the products we’ve reviewed, which matters for trust, separate from the raw percentage results.

Is NMN legal now?

Yes. The FDA resolved a roughly three-year regulatory gray period in September and December 2025, confirming NMN’s lawful status as a dietary supplement.

Does raising NAD+ actually slow aging?

The evidence solidly shows both NMN and NR raise NAD+ levels in a dose-dependent way, plus some secondary benefits like improved insulin sensitivity or endurance in specific studies. Evidence directly linking that to slower aging or reduced disease risk in humans is still developing.

Do I need a prescription for either?

No. Both are over-the-counter dietary supplements, not prescription medications.

Ready to compare the full reviews?

Read Our Tru Niagen Review

Last reviewed: September 2026 · Read our full rating methodology.

Health Supplements Lab Editorial Team
Health Supplements Lab Editorial Team

Health Supplements Lab was founded to bring a more rigorous, evidence-first standard to men's wellness supplement reviews. Every product featured on this site is evaluated against the same fixed criteria — ingredient dosing, available evidence, manufacturer transparency, and independently verified user feedback — regardless of commission rate.

We are not doctors or medical professionals, and nothing on this site is medical advice. Our credibility comes from the transparency of our process, not from unearned credentials.

Articles: 30

Leave a Reply

Your email address will not be published. Required fields are marked *